Naccarelli, Gerald V.

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

Cappato, R., Marchlinski, F. E., Hohnloser, S. H., Naccarelli, G. V., Xiang, J., Wilber, D. J., Ma, C.-S., Hess, S., Wells, D. S., Juang, G., et al. (2015) · European Heart Journal

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 422

Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: A Randomized Controlled Trial

Kowey, P. R., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., & Pratt, C. M. (2010) · JAMA

Atrial Fibrillation Management and OutcomesFatty Acid Research and Health

Cited by 201

Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope

Gulamhusein, S., Naccarelli, G. V., Ko, P. T., Prystowsky, E. N., Zipes, D. P., Barnett, H. J. M., Heger, J. J., & Klein, G. J. (1982) · The American Journal of Medicine

Cardiovascular Syncope and Autonomic DisordersCardiac electrophysiology and arrhythmias

Cited by 177

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Steinberg, B. A., Kim, S., Fonarow, G. C., Thomas, L., Ansell, J., Kowey, P. R., Mahaffey, K. W., Gersh, B. J., Hylek, E., Naccarelli, G., et al. (2014) · American Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 154

Report of the NASPE Policy Conference on Arrhythmias and the Athlete

ESTES, N. A. M., LINK, M. S., CANNOM, D., NACCARELLI, G. V., PRYSTOWSKY, E. N., MARON, B. J., & OLSHANSKY, B. (2001) · Journal of Cardiovascular Electrophysiology

Cardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

Cited by 95